Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 71
Filter
1.
Rev Bras Enferm ; 77(2): e20220625, 2024.
Article in English | MEDLINE | ID: mdl-38747809

ABSTRACT

OBJECTIVE: To identify predictors of stunting among children 0-24 months in Southeast Asia. METHODS: This scoping review focused on articles with observational study design in English published from 2012 to 2023 from five international databases. The primary keyword used were: "stunting" OR "growth disorder" AND "newborn" AND "predict" AND "Southeast Asia". RESULTS: Of the 27 articles selected for the final analysis there are thirteen predictors of stunting in seven Southeast Asia countries. The thirteen predictors include the child, mother, home, inadequate complementary feeding, inadequate breastfeeding, inadequate care, poor quality foods, food and water safety, infection, political economy, health and healthcare, water, sanitation, and environment, and social culture factor. CONCLUSION: All these predictors can lead to stunting in Southeast Asia. To prevent it, health service providers and other related sectors need to carry out health promotion and health prevention according to the predictors found.


Subject(s)
Growth Disorders , Humans , Asia, Southeastern/epidemiology , Infant , Growth Disorders/epidemiology , Infant, Newborn , Child, Preschool , Female , Risk Factors
2.
Am J Trop Med Hyg ; 106(1): 33-37, 2021 11 29.
Article in English | MEDLINE | ID: mdl-34844214

ABSTRACT

Tropical alluvial gold and gem miners are often an especially at-risk population for malaria infection. Geographical areas of mining-associated malaria epidemics in the recent past include Southeast Asia (Cambodia, Thailand, and Myanmar); the Amazon basin (Brazil, French Guyana, Suriname, Columbia, and Peru); and tropical Africa. Mobile populations of young adult men engaged in the hard labor of mining may experience severe malaria especially if they lack preexisting immunity and are irregularly consuming antimalarial drugs. Particular problems occur because much of this informal mining activity is illegal and done in isolated areas without access to health services and with evidence of emerging antimalarial drug resistance. Concentrating vulnerable populations in an ecologically disturbed landscape is often conducive to epidemics, which can then spread as these highly mobile workers return to their homes. Mining-associated malaria endangers malaria elimination efforts and miners need to be addressed as a group of particular concern.


Subject(s)
Malaria/epidemiology , Miners , Africa/epidemiology , Antimalarials/therapeutic use , Asia, Southeastern/epidemiology , Epidemics , Humans , Male , Mining , South America/epidemiology , Vulnerable Populations , Young Adult
3.
Dermatology ; 237(2): 236-247, 2021.
Article in English | MEDLINE | ID: mdl-32101870

ABSTRACT

Podoconiosis is a form of lymphoedema that occurs in tropical highland areas in genetically susceptible individuals who are exposed to irritant volcanic soils. The disease is preventable through consistent use of footwear and attention to foot hygiene; however, in endemic areas there is a strong barefoot tradition, and many cannot afford shoes. Patients with podoconiosis face significant physical disability, psychological comorbidity, reduced quality of life and experience frequent episodes of systemic illness due to acute dermatolymphangioadenitis. This review provides an overview of this important and neglected tropical skin disease and summarizes the latest research findings.


Subject(s)
Clay , Cost of Illness , Elephantiasis/etiology , Africa South of the Sahara/epidemiology , Asia, Southeastern/epidemiology , Central America/epidemiology , Elephantiasis/diagnosis , Elephantiasis/epidemiology , Elephantiasis/therapy , Genetic Predisposition to Disease , Humans , Mental Health , Neglected Diseases , Shoes , Social Stigma , South America/epidemiology
4.
Medicine (Baltimore) ; 99(49): e23489, 2020 Dec 04.
Article in English | MEDLINE | ID: mdl-33285754

ABSTRACT

BACKGROUND: The effects of sodium-glucose cotransporter-2 inhibitors (SGLT2is) and glucagon-like peptide 1 receptor agonists on major adverse cardiovascular events (MACE) in type 2 diabetic subgroups defined by race, ethnicity, and region are unestablished. METHODS: We searched PubMed and Embase for related randomized controlled trials. We conducted random-effects meta-analysis, stratified by drug class, on MACE in various subgroups defined by 3 factors of interest (ie, race, ethnicity, and region) to estimate pooled hazard ratio (HR) and 95% confidence interval. Random-effects meta-regression was conducted to evaluate the differences between 2 drug classes. RESULTS: We included 11 randomized controlled trials for pooled analysis. Compared with placebo, SGLT2is and GLP-1 RAs significantly reduced the risk of MACE (HR ranged from 0.76 to 0.93) in most diabetic subgroups defined by 3 factors of interest. The 2 drug classes did not significantly reduced this risk in the Black race group (HR 0.92, 95% confidence interval 0.70-1.20). The effect of the 2 drug classes on MACE was not significantly different in all diabetic subgroups of interest (P-value for subgroup differences ranged from .101 to .971). CONCLUSIONS: SGLT2is and glucagon-like peptide 1 receptor agonists can significantly reduce the risk of MACE in most type 2 diabetic subgroups defined by race, ethnicity, and region, whereas they fail to do it in Black individuals.


Subject(s)
Cardiovascular Diseases/ethnology , Diabetes Mellitus, Type 2/ethnology , Ethnicity/statistics & numerical data , Glucagon-Like Peptide-1 Receptor/agonists , Hypoglycemic Agents/therapeutic use , Racial Groups/statistics & numerical data , Sodium-Glucose Transporter 2 Inhibitors/therapeutic use , Adult , Asia, Southeastern/epidemiology , Black People/statistics & numerical data , Cardiovascular Diseases/epidemiology , Cardiovascular Diseases/prevention & control , Cardiovascular System/drug effects , Diabetes Mellitus, Type 2/complications , Diabetes Mellitus, Type 2/drug therapy , Europe/epidemiology , Female , Humans , Male , Middle Aged , North America/epidemiology , Proportional Hazards Models , Randomized Controlled Trials as Topic , Risk Factors , South America/epidemiology
6.
Infect Control Hosp Epidemiol ; 41(5): 553-563, 2020 05.
Article in English | MEDLINE | ID: mdl-32183925

ABSTRACT

BACKGROUND: Short-term peripheral venous catheter-related bloodstream infection (PVCR-BSI) rates have not been systematically studied in resource-limited countries, and data on their incidence by number of device days are not available. METHODS: Prospective, surveillance study on PVCR-BSI conducted from September 1, 2013, to May 31, 2019, in 727 intensive care units (ICUs), by members of the International Nosocomial Infection Control Consortium (INICC), from 268 hospitals in 141 cities of 42 countries of Africa, the Americas, Eastern Mediterranean, Europe, South East Asia, and Western Pacific regions. For this research, we applied definition and criteria of the CDC NHSN, methodology of the INICC, and software named INICC Surveillance Online System. RESULTS: We followed 149,609 ICU patients for 731,135 bed days and 743,508 short-term peripheral venous catheter (PVC) days. We identified 1,789 PVCR-BSIs for an overall rate of 2.41 per 1,000 PVC days. Mortality in patients with PVC but without PVCR-BSI was 6.67%, and mortality was 18% in patients with PVC and PVCR-BSI. The length of stay of patients with PVC but without PVCR-BSI was 4.83 days, and the length of stay was 9.85 days in patients with PVC and PVCR-BSI. Among these infections, the microorganism profile showed 58% gram-negative bacteria: Escherichia coli (16%), Klebsiella spp (11%), Pseudomonas aeruginosa (6%), Enterobacter spp (4%), and others (20%) including Serratia marcescens. Staphylococcus aureus were the predominant gram-positive bacteria (12%). CONCLUSIONS: PVCR-BSI rates in INICC ICUs were much higher than rates published from industrialized countries. Infection prevention programs must be implemented to reduce the incidence of PVCR-BSIs in resource-limited countries.


Subject(s)
Bacteremia/epidemiology , Bacteremia/etiology , Catheter-Related Infections/epidemiology , Catheter-Related Infections/microbiology , Cross Infection/epidemiology , Cross Infection/microbiology , Advisory Committees , Africa/epidemiology , Americas/epidemiology , Asia, Southeastern/epidemiology , Central Venous Catheters/microbiology , Cities , Europe/epidemiology , Hospitals , Humans , Infection Control , Intensive Care Units , Mediterranean Islands/epidemiology , Multicenter Studies as Topic , Pacific Islands/epidemiology , Prospective Studies , Sentinel Surveillance
7.
Alcohol Clin Exp Res ; 44(1): 141-151, 2020 01.
Article in English | MEDLINE | ID: mdl-31774575

ABSTRACT

BACKGROUND: While research in high-income countries (HICs) has established high costs associated with alcohol's harm to others (AHTO) in the workplace, scant attention has been paid to AHTO in the workplace in lower- or middle-income countries (LMICs). AIM: To compare estimates and predictors of alcohol's impacts upon coworkers among workers in 12 countries. METHODS: Cross-sectional surveys from 9,693 men and 8,606 women employed in Switzerland, Australia, the United States, Ireland, New Zealand, Chile, Nigeria, Lao PDR, Thailand, Vietnam, India, and Sri Lanka. Five questions were asked about harms in the past year because of coworkers' drinking: Had they (i) covered for another worker; (ii) worked extra hours; (iii) been involved in an accident or close call; or had their (iv) own productivity been reduced; or (v) ability to do their job been affected? Logistic regression and meta-analyses were estimated with 1 or more harms (vs. none) as the dependent variable, adjusting for age, sex, rurality of location, and the respondent worker's own drinking. RESULTS: Between 1% (New Zealand) and 16% (Thailand) of workers reported that they had been adversely affected by a coworker's drinking in the previous year (with most countries in the 6 to 13% range). Smaller percentages (<1% to 12%) reported being in an accident or close call due to others' drinking. Employed men were more likely to report harm from coworkers' drinking than employed women in all countries apart from the United States, New Zealand, and Vietnam, and own drinking pattern was associated with increased harm in 5 countries. Harms were distributed fairly equally across age and geographic regions. Harm from coworkers' drinking was less prevalent among men in HICs compared with LMICs. CONCLUSIONS: Workforce impairment because of drinking extends beyond the drinker in a range of countries and impacts productivity and economic development, particularly affecting men in LMICs.


Subject(s)
Alcohol Drinking/epidemiology , Alcohol Drinking/psychology , Harm Reduction , Occupational Health/trends , Workplace/psychology , Adolescent , Adult , Alcohol Drinking/legislation & jurisprudence , Alcohol Drinking/prevention & control , Asia, Southeastern/epidemiology , Australia/epidemiology , Chile/epidemiology , Cross-Sectional Studies , Europe/epidemiology , Female , Humans , India/epidemiology , Male , New Zealand/epidemiology , Nigeria/epidemiology , Occupational Health/legislation & jurisprudence , United States/epidemiology , Workplace/legislation & jurisprudence , Young Adult
9.
Nutrients ; 12(1)2019 Dec 27.
Article in English | MEDLINE | ID: mdl-31892187

ABSTRACT

BACKGROUND: In many developing countries, nutritional and epidemiological transitions are contributing to continuous undernutrition and escalating overnutrition, resulting in coexisting forms of malnutrition often referred as the "double burden of malnutrition" (DBM). This complex phenomenon constitutes an unprecedented challenge to global public health and has been prioritized by international health organizations, prompting governments to swift action. Specifically, five years ago the World Health Organization proposed a roadmap to tackle the DBM though so-called "double-duty actions". The objective of this review was to synthesize the literature on interventions which address the DBM. METHODS: We developed a scoping review to identify interventions addressing the DBM. We searched PUBMED for papers reporting interventions until December 2019. Articles examining interventions, government policies, or tools at the individual, household, or community level to address the double burden of malnutrition were included. RESULTS: Seven articles met the inclusion criteria. Three were from sub-Saharan Africa, one was from Southeast Asia, and one was from Central America. Two were modelling studies, with one covering 24 low-income countries and the other focusing on Ghana. CONCLUSION: Notwithstanding the pressing issue of the DBM, there is a paucity of studies examining double-duty actions despite the attention that it has garnered within the global nutrition community. Whilst nutrient deficiencies may be curbed by poverty reduction measures, for obesity prevention nutrition, education and promotion of physical activity, along with the encouragement of local food production, may be instrumental.


Subject(s)
Malnutrition/epidemiology , Malnutrition/prevention & control , Overnutrition/epidemiology , Overnutrition/prevention & control , Adolescent , Africa South of the Sahara/epidemiology , Asia, Southeastern/epidemiology , Central America/epidemiology , Child , Developing Countries/statistics & numerical data , Exercise , Female , Health Education , Humans , Poverty , PubMed , World Health Organization
10.
Parasit Vectors ; 11(1): 613, 2018 Nov 29.
Article in English | MEDLINE | ID: mdl-30497522

ABSTRACT

BACKGROUND: Due to the relative short life span and the limited spatial movement, porcine cysticercosis is an excellent indicator of current local active transmission. The aim of this study was to map at province-level, the occurrence of T. solium and T. asiatica in pigs and areas at risk of transmission to pigs in East and Southeast Asia, based on the density of extensive pig production systems and confirmed reports of porcine cysticercosis. METHODS: This study covered East and Southeast Asia, which consist of the following countries: Brunei, Cambodia, China, East Timor, Indonesia, Japan, Laos, Malaysia, Mongolia, Myanmar, North Korea, Philippines, Singapore, South Korea, Thailand and Vietnam. Literature searches were carried out to identify current epidemiological data on the occurrence of porcine cysticercosis caused by T. solium and T. asiatica infections. Modelled densities of pigs in extensive production systems were mapped and compared to available data on porcine cysticercosis. RESULTS: Porcine cysticercosis was confirmed to be present during the period 2000 to 2018 in eight out of the 16 countries included in this study. Taenia solium porcine cysticercosis was confirmed from all eight countries, whereas only one country (Laos) could confirm the presence of T. asiatica porcine cysticercosis. Province-level occurrence was identified in five countries (Cambodia, Indonesia, Laos, Myanmar, and Vietnam) across 19 provinces. Smallholder pig keeping is believed to be widely distributed throughout the region, with greater densities predicted to occur in areas of China, Myanmar, Philippines and Vietnam. CONCLUSIONS: The discrepancies between countries reporting taeniosis and the occurrence of porcine cysticercosis, both for T. solium and T. asiatica, suggests that both parasites are underreported. More epidemiological surveys are needed to determine the societal burden of both parasites. This study highlights a straightforward approach to determine areas at risk of porcine cysticercosis in the absence of prevalence data.


Subject(s)
Cysticercosis/parasitology , Cysticercosis/veterinary , Swine Diseases/parasitology , Taenia solium/isolation & purification , Taenia/isolation & purification , Animals , Asia, Southeastern/epidemiology , Cysticercosis/epidemiology , Asia, Eastern/epidemiology , Humans , Swine , Swine Diseases/epidemiology , Taenia/classification , Taenia/genetics , Taenia solium/classification , Taenia solium/genetics
11.
Am J Trop Med Hyg ; 99(3_Suppl): 89-96, 2018 09.
Article in English | MEDLINE | ID: mdl-30047361

ABSTRACT

The Tackling Typhoid supplement shows that typhoid fever continues to be a problem globally despite socioeconomic gains in certain settings. Morbidity remains high in many endemic countries, notably in sub-Saharan Africa and South Asia. In addition, antimicrobial resistance is a growing issue that poses a challenge for clinical management. The findings from this supplement revealed that outside of high-income countries, there were few reliable population-based estimates of typhoid and paratyphoid fever derived from surveillance systems. This indicates the need for monitoring systems that can also characterize the effectiveness of interventions, particularly in low- and middle-income settings. The country case studies indicated that gains in economic conditions, education, and environmental health may be associated with reductions in typhoid fever burden. Over the study period, the effect is mainly notable in countries with higher baseline levels of economic development, female literacy, and investments in public sanitation. High burden countries must continue to invest in strategies at the local level to address environmental factors such as access to safe drinking water and improved public sanitation that are known to interrupt transmission or diminish the risk of acquiring typhoid. Developing more effective vaccines and incorporating appropriate immunization strategies that target populations with the greatest risk could potentially alleviate disease burden.


Subject(s)
Anti-Bacterial Agents/pharmacology , Paratyphoid Fever/epidemiology , Paratyphoid Fever/prevention & control , Typhoid Fever/epidemiology , Typhoid Fever/prevention & control , Africa South of the Sahara/epidemiology , Asia, Southeastern/epidemiology , Asia, Western/epidemiology , Chile/epidemiology , Food Safety , Global Health , Humans , Paratyphoid Fever/economics , Paratyphoid Fever/microbiology , Public Health , Sanitation , Typhoid Fever/economics , Typhoid Fever/microbiology
12.
J Vector Borne Dis ; 55(1): 1-8, 2018.
Article in English | MEDLINE | ID: mdl-29916441

ABSTRACT

Malaria, caused by the protozoan parasites of the genus Plasmodium, is a major health problem in many countries of the world. Five parasite species namely, Plasmodium falciparum, P. vivax, P. malariae, P. ovale, and P. knowlesi, cause malaria in humans. Of these, P. falciparum and P. vivax are the most prevalent and account for the majority of the global malaria cases. In most areas of Africa, P. vivax infection is essentially absent because of the inherited lack of Duffy antigen receptor for chemokines on the surface of red blood cells that is involved in the parasite invasion of erythrocytes. Therefore, in Africa, most malaria infections are by P. falciparum and the highest burden of P. vivax infection is in Southeast Asia and South America. Plasmodium falciparum is the most virulent and as such, it is responsible for the majority of malarial mortality, particularly in Africa. Although, P. vivax infection has long been considered to be benign, recent studies have reported life-threatening consequences, including acute respiratory distress syndrome, cerebral malaria, multi-organ failure, dyserythropoiesis and anaemia. Despite exhibiting low parasite biomass in infected people due to parasite's specificity to infect only reticulocytes, P. vivax infection triggers higher inflammatory responses and exacerbated clinical symptoms than P. falciparum, such as fever and chills. Another characteristic feature of P. vivax infection, compared to P. falciparum infection, is persistence of the parasite as dormant liver-stage hypnozoites, causing recurrent episodes of malaria. This review article summarizes the published information on P. vivax epidemiology, drug resistance and pathophysiology.


Subject(s)
Antimalarials/pharmacology , Drug Resistance , Malaria, Vivax/epidemiology , Malaria, Vivax/physiopathology , Plasmodium vivax/drug effects , Pregnancy Complications, Parasitic/epidemiology , Antimalarials/adverse effects , Antimalarials/therapeutic use , Asia, Southeastern/epidemiology , Female , Humans , Inflammation/parasitology , Liver/parasitology , Malaria, Vivax/complications , Malaria, Vivax/drug therapy , Male , Plasmodium vivax/immunology , Plasmodium vivax/pathogenicity , Pregnancy , Pregnancy Complications, Parasitic/physiopathology , Recurrence , South America/epidemiology
13.
Br J Anaesth ; 120(4): 790-797, 2018 Apr.
Article in English | MEDLINE | ID: mdl-29576119

ABSTRACT

BACKGROUND: A previous PAIN OUT study found that American orthopaedic-surgical patients rated 'worst pain' higher than did similar European patients. This study aims to confirm these findings in a larger, international patient sample, explore whether risk factors for greater postoperative pain exist disproportionately in the American population, and confirm the findings for one procedure. METHODS: Surveyors collected patient reported outcomes (PROs) and perioperative pain management practices using PAIN OUT methodology. Most PROs used 11-point numerical rating scales (0=null, 10=worst possible). Risk factors included: female gender, younger age, high BMI, chronic pain, and opioid use before surgery. Initial analysis used a mixed patient cohort. A secondary analysis used only patients undergoing total knee replacement (TKR). Inference was based primarily on effect size using Cohen's d. RESULTS: 13,770 patients in 13 European and non-European countries (international ) and 564 patients from the United States (US) contributed data on the 1st postoperative day. Three of 11 PROs differed between the cohorts: 'worst pain' {US 7.5 (2.5) vs international 5.6 (2.8); d=0.66 [confidence interval (CI) 0.58-0.75]}; proportion 'receiving information about treatment options' [US 0.86 vs international 0.66; d=0.53 (CI 0.39-0.66)]; reporting adverse effects and their severity [US 0.87 vs international 0.73; d=0.52 (CI 0.38-0.66)]. Risk factors did not differ between the two cohorts. PROs and management patterns in TKR patients were similar to the mixed cohort. CONCLUSIONS: Three PROs differed between international and US patients, with higher 'worst pain' for US patients. Neither risk factors, nor patient mix accounted for the observed differences for 'worst pain'. CLINICAL TRIAL REGISTRATION: NCT 02083835.


Subject(s)
Orthopedic Procedures , Pain, Postoperative/epidemiology , Patient Reported Outcome Measures , Adolescent , Adult , Africa/epidemiology , Age Factors , Aged , Aged, 80 and over , Asia, Southeastern/epidemiology , Body Mass Index , Chronic Pain , Cross-Sectional Studies , Europe/epidemiology , Female , Humans , Male , Middle Aged , Risk Factors , Severity of Illness Index , Sex Factors , South America/epidemiology , United States/epidemiology , Young Adult
14.
ANZ J Surg ; 88(9): 842-847, 2018 09.
Article in English | MEDLINE | ID: mdl-29205748

ABSTRACT

BACKGROUND: The medical tourism industry, and in particular cosmetic tourism for breast augmentation, is becoming an increasingly popular global phenomenon. The objective of this study is to determine the extent of medical literature and the patient risk profiles associated with cosmetic tourism for breast augmentation both locally and abroad. DATA SOURCES: OVID MEDLINE, OVID Embase, Cochrane Central and Proquest electronic databases. METHODS: The search was conducted through to April 2017. Studies pertaining entirely or partly to cosmetic tourism for breast augmentation were considered for inclusion. Exclusion criteria included non-English articles, studies relating to non-cosmetic or non-implant breast augmentation, and studies that did not separately report on findings associated with breast augmentation abroad. RESULTS: We identified 17 observational studies. Common destinations included Europe, South America and South East Asia. Infectious complications were common. Wound dehiscence and aesthetic dissatisfaction also featured. Catastrophic outcomes such as sepsis, intubation and ventilation, radical bilateral mastectomy, irreversible hypoxic brain injury and death were also reported. There were expectations that home country health systems would treat complications and provide non-medically indicated revision procedures. The burden on home country health systems was evident from a public health perspective. CONCLUSION: Determining the extent of cosmetic tourism for breast augmentation, including outcomes and complications, will help to inform Australian patients who this seek procedure abroad. Furthermore, it will aid in better understanding the health system implications and may help to guide future research and public health interventions both locally and internationally.


Subject(s)
Breast/surgery , Mammaplasty/adverse effects , Medical Tourism/statistics & numerical data , Adolescent , Adult , Asia, Southeastern/epidemiology , Australia/epidemiology , Cosmetic Techniques/adverse effects , Cosmetic Techniques/economics , Cosmetic Techniques/trends , Europe/epidemiology , Female , Humans , Mammaplasty/economics , Medical Tourism/economics , Meta-Analysis as Topic , Middle Aged , Observational Studies as Topic , Postoperative Complications/epidemiology , Postoperative Complications/etiology , Postoperative Complications/pathology , Risk , South America/epidemiology , Young Adult
16.
Am J Trop Med Hyg ; 96(5): 1222-1226, 2017 May.
Article in English | MEDLINE | ID: mdl-28193746

ABSTRACT

AbstractDengue virus infections have adversely impacted U.S. military operations since the Spanish-American War. The erosion of mission capabilities and lost duty days are underestimated. Appreciating the incidence and prevalence of dengue infections in U.S. military personnel is important to inform disease prevention strategies. Banked pre- and post-deployment serum samples from 1,000 U.S. military personnel with a single deployment to a dengue-endemic region were tested using a screening microneutralization assay to detect anti-dengue-virus-neutralizing antibodies. A total of 76 (7.6%) post-deployment samples were positive and 15 of the pre-deployment samples were negative. These figures represent an infection incidence of 1.5% and total of 17.6 seroconversions per 10,000 deployment months. These data represent a deploying military population with a relatively high background rate of dengue seropositivity, a low level of infection during deployment compared with background infection rates in the local populations, and the potential for worsening clinical attack rates with increased frequency of deployment. Additional studies are required to more clearly elucidate the dengue infection and disease risk in U.S. military personnel.


Subject(s)
Antibodies, Viral/blood , Dengue Virus/immunology , Dengue/epidemiology , Endemic Diseases , Military Personnel , Adult , Africa/epidemiology , Asia, Southeastern/epidemiology , Blood Banks , Central America/epidemiology , Dengue/blood , Dengue/virology , Dengue Virus/isolation & purification , Female , Humans , Immune Sera/chemistry , Male , Middle Aged , Retrospective Studies , Seroepidemiologic Studies , Travel , United States/epidemiology
17.
Nicotine Tob Res ; 19(12): 1401-1407, 2017 Nov 07.
Article in English | MEDLINE | ID: mdl-27679607

ABSTRACT

INTRODUCTION: Previous evidence linked low socioeconomic status with higher smoking prevalence. Our objective was to assess the strength of this association in the world population, updating a previous work. METHODS: Systematic review and meta-analysis of observational studies. Subgroup analyses included continents, WHO regions, country mortality levels, gender, age, risk of bias, and study publication date. Independent reviewers selected studies, assessed potential bias and extracted data. We searched MEDLINE, EMBASE, CENTRAL, SOCINDEX, AFRICAN INDEX MEDICUS, and LILACS, and other sources from 1989 to 2013 reporting direct measurements of income and current cigarette smoking. RESULTS: We retrieved 13,583 articles and included 93 for meta-analysis. Median smoking prevalence was 17.8% (range 3-70%). Lower income was consistently associated with higher smoking prevalence (odds ratio [OR]: 1.45; 95% confidence interval [CI]: 1.35-1.56). This association was statistically significant in the subgroup analysis by WHO regions for the Americas (OR: 1.54; 95% CI: 1.42-1.68), South East Asia (OR: 1.53; 95% CI: 1.10-2.00), Europe (OR: 1.45; 95% CI: 1.29-1.63), and Western Pacific (OR: 1.32; 95% CI: 1.02-1.72), and in studies conducted during 1990s (OR: 1.42; 95% CI: 1.24-1.62) and 2000s (OR: 1.48; 95%CI: 1.30-1.64). Likewise, it was noted in low-mortality countries (OR: 1.48; 95% CI: 1.37-1.60) and for both genders. Prevalence was highest in the lowest income levels compared to the middle (OR: 1.69; 95% CI: 1.49-1.92), followed by the middle level compared to the highest (OR: 1.31; 95% CI: 1.20-1.43). CONCLUSIONS: Our results show that current cigarette smoking was significantly associated with lower income worldwide and across subgroups, suggesting a dose-response relationship. IMPLICATIONS: This unique updated systematic review shows a consistent inverse dose-response relationship between cigarette smoking and income level, present among most geographical areas and country characteristics. Public health measures should take into account this potential inequity and consider special efforts directed to disadvantaged populations.


Subject(s)
Cigarette Smoking/economics , Cigarette Smoking/epidemiology , Income , Adult , Americas/epidemiology , Asia, Southeastern/epidemiology , Europe/epidemiology , Female , Humans , Male , Middle Aged , Observational Studies as Topic/methods , Poverty/economics , Prevalence , Social Class , Vulnerable Populations
18.
J Travel Med ; 23(3)2016 Mar.
Article in English | MEDLINE | ID: mdl-27356308

ABSTRACT

BACKGROUND: Dengue is an arboviral disease estimated to cause 50-100 million infections each year in >100 tropical and subtropical countries. Urbanization, human population growth and expanded global travel have resulted in an increase in the incidence of dengue worldwide. International travellers to areas with endemic dengue are at risk of contracting dengue and US Peace Corps Volunteers are one specific group of long-term travellers who are exposed to environments where dengue can be contracted. METHODS: Cases of dengue among Peace Corps Volunteers, defined as clinically apparent infections with laboratory-confirmation by a positive NS1 antigen test, demonstration of IgM antibodies or by a 4-fold increase in IgG antibodies, between 1 January 2000 and 31 December 2014, reported to the Peace Corps' Epidemiologic Surveillance System were analyzed. RESULTS: Overall there were 1448 cases of dengue reported among Volunteers, with an incidence rate of 1.12 cases per 1000 Volunteer-months (95% CI 1.06-1.17). The highest rate of dengue among Volunteers was reported in the Caribbean region, with a rate of 5.51 cases per 1000 Volunteer-months (95% CI 4.97-6.10), followed by the East Asia/South Asia region (3.34, 95% CI 2.96-3.75) and Central America (2.55, 95% CI 2.32-2.79). The rate of dengue peaked in 2007, 2010 and 2013. Each peak year was followed by a trough year. CONCLUSIONS: Globally, there appears to be a 3-year cyclical pattern of dengue incidence among Volunteers, with differences by region. Dengue continues to be a priority health issue for travellers to endemic areas, and enhanced surveillance of dengue among international travellers may result in improved patient education and prevention efforts.


Subject(s)
Dengue/epidemiology , Peace Corps , Travel , Volunteers/statistics & numerical data , Adult , Asia, Southeastern/epidemiology , Caribbean Region/epidemiology , Central America/epidemiology , Dengue Virus , Female , Humans , Incidence , Male , Risk Factors , United States , Young Adult
19.
Mayo Clin Proc ; 91(4): 514-21, 2016 Apr.
Article in English | MEDLINE | ID: mdl-27046524

ABSTRACT

Zika virus has recently emerged as a new public health threat. An arthropod-borne virus named after the Zika forest in Uganda, it was first discovered in 1947. The virus caused only sporadic cases of Zika infection in Africa and Southeast Asia until 2007, when the first large outbreak occurred in the Yap State in the Federated States of Micronesia. Another outbreak in French Polynesia in 2013 was notable for being associated temporally with an increase in cases of Guillain-Barré syndrome. In 2015, the virus was first reported in Brazil and since then has spread explosively through several additional countries in South and Central America and the Caribbean. Simultaneously, several of these countries have seen a dramatic increase in the incidence of infants born with microcephaly. The rapid spread of Zika virus through the Americas, together with the association of infection with microcephaly and Guillain-Barré syndrome, has resulted in the World Health Organization declaring a public health emergency. Zika virus has the potential to spread to new areas where the Aedes mosquito vector is present and therefore presents a risk to the United States. This concise review describes the clinical features of Zika virus infection and provides advice for clinicians on counseling travelers and others about the disease.


Subject(s)
Disease Outbreaks/history , Guillain-Barre Syndrome/epidemiology , Microcephaly/epidemiology , Microcephaly/virology , Zika Virus Infection/epidemiology , Zika Virus Infection/history , Zika Virus/isolation & purification , Americas/epidemiology , Animals , Asia, Southeastern/epidemiology , Brazil/epidemiology , Disease Outbreaks/statistics & numerical data , Female , History, 20th Century , History, 21st Century , Humans , Incidence , Infant, Newborn , Male , Micronesia/epidemiology , Polynesia/epidemiology , Uganda/epidemiology , Zika Virus Infection/transmission
SELECTION OF CITATIONS
SEARCH DETAIL